Article
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers.
International journal of cancer - 15 Mar 2012
Dick Michelle G, Versmold Beatrix, Engel Christoph, Meindl Alfons, Arnold Norbert, Varon-Mateeva Raymonda, Sutter Christian, Niederacher Dieter, Deissler Helmut, Preisler-Adams Sabine, Kast Karin, Schäfer Dieter, Gadzicki Dorothea, Heinritz Wolfram, Wappenschmidt Barbara, Schmutzler Rita K
Abstract excerpt
Dysregulation of apoptosis plays an important role in carcinogenesis. Therefore, apoptosis-associated genes like the death receptor 4 (DR4, TRAIL-R1) are interesting candidates for modifying the penetrance of breast and ovarian cancer in carriers of BRCA1 and BRCA2 mutations. The DR-4 haplotype 626C-683C [626C > G, Thr209Arg (rs4871857) and 683A > C, Glu228Ala (rs17088993)] has recently been linked to an...
Read the complete abstract on PubMed